Water-soluble compound
First Claim
1. A process for treating a stent comprising the steps of a. applying a magnetic field to a patient such that said magnetic field acts upon a stent wherein i. said stent is disposed within a lumen of said patient, said stent having a first magnetic moment, said stent being further comprised of means to change said first magnetic moment to a second magnetic moment, ii. said stent is comprised of a substrate wherein said substrate is comprised of a biologically active substrate and a magnetic moiety wherein:
- 1. said biologically active substrate is an anti-mitotic agent, 2. said magnetic moiety is covalently bound to said biologically active substrate, said magnetic moiety having a third magnetic moment, iii. said third magnetic moment and said first magnetic moment are such that there is an attractive force between said stent and said substrate, iv. said second magnetic moment and said first magnetic moment are such that there is a repulsive force between said stent and said substrate, b. in response to said magnetic field, said first magnetic moment of said stent changes to said second magnetic moment, thereby causing said substrate to be repelled by said stent.
1 Assignment
0 Petitions
Accused Products
Abstract
A water-soluble magnetic anti-mitotic compound with a water-solubility of at least 100 micrograms per milliliter, a molecular weight of at least 150 grams per mole, a mitotic index factor of at least 10 percent, a positive magnetic susceptibility of at least 1,000×10−6 cgs, and a magnetic moment of at least 0.5 bohr magnetrons, wherein said compound is comprised of at least 7 carbon atoms and at least one inorganic atom with a positive magnetic susceptibility of at least 200×10−6 cgs.
120 Citations
20 Claims
-
1. A process for treating a stent comprising the steps of
a. applying a magnetic field to a patient such that said magnetic field acts upon a stent wherein i. said stent is disposed within a lumen of said patient, said stent having a first magnetic moment, said stent being further comprised of means to change said first magnetic moment to a second magnetic moment, ii. said stent is comprised of a substrate wherein said substrate is comprised of a biologically active substrate and a magnetic moiety wherein: -
1. said biologically active substrate is an anti-mitotic agent, 2. said magnetic moiety is covalently bound to said biologically active substrate, said magnetic moiety having a third magnetic moment, iii. said third magnetic moment and said first magnetic moment are such that there is an attractive force between said stent and said substrate, iv. said second magnetic moment and said first magnetic moment are such that there is a repulsive force between said stent and said substrate, b. in response to said magnetic field, said first magnetic moment of said stent changes to said second magnetic moment, thereby causing said substrate to be repelled by said stent. - View Dependent Claims (2, 3, 4, 5, 6)
-
-
7. A process for treating a stent comprising the steps of
a. applying a magnetic field to a patient such that said magnetic field acts upon a stent wherein i. said stent is disposed within a lumen of said patient, said stent having a first magnetic moment, said stent being further comprised of means to change said first magnetic moment to a second magnetic moment, ii. said stent is comprised of a substrate wherein said substrate is comprised of a biologically active substrate and a magnetic moiety wherein: -
1. said biologically active substrate is an antimitotic agent, 2. said magnetic moiety is covalently bound to said biologically active substrate, said magnetic moiety having a third magnetic moment iii. said third magnetic moment and said first magnetic moment are such that there Is a repulsive force between said stent and said substrate, iv. said second magnetic and said first magnetic moment are such that there is an attractive force between said stent and said substrate, b. in response to said magnetic field, said first magnetic moment of said stent changes to said second magnetic moment, thereby causing said substrate to be attracted to said stent. - View Dependent Claims (8, 9, 10, 11, 12, 13)
-
-
14. A process for treating a stent comprising the steps of
a. applying a magnetic field to a patient such that said magnetic field acts upon a stent wherein i. said stent is disposed within a lumen of said patient, said stent having a first magnetic moment, said stent being further comprised of means to change said first magnetic moment to a second magnetic moment, ii. said stent is comprised of a substrate wherein said substrate is comprised of a biologically active substrate and a magnetic moiety wherein: -
1. said biologically active substrate is a taxane, 2. said magnetic moiety is covalently bound to said biologically active substrate, said magnetic moiety having a third magnetic moment, iii. said third magnetic moment and said first magnetic moment are such that there is an attractive force between said stent and said substrate, iv. said second magnetic and said first magnetic moment are such that there is a repulsive force between said stent and said substrate, b. in response to said magnetic field, said first magnetic moment of said stent changes to said second magnetic moment, thereby causing said substrate to be repelled by said stent. - View Dependent Claims (15, 16, 17, 18, 19, 20)
-
Specification